By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antineoplastics > Xpovio 40 mg twice-weekly
Miscellaneous antineoplastics

Xpovio 40 mg twice-weekly

https://themeditary.com/drug/xpovio-40-mg-twice-weekly-22897.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Oct 19, 2023  Additional Content by TheMediTary.Com

Generic name: selinexor [ sel-i-nex-or ]

Drug class: Miscellaneous antineoplastics

Availability: Prescription only

Pregnancy & Lactation: Risk data not available

Brand names: Xpovio, Selinexor, Xpovio 40 mg once-weekly, Xpovio 60 mg twice-weekly, Xpovio 80 mg twice-weekly

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Xpovio 40 mg twice-weekly?

Xpovio 40 mg twice-weekly is used together with bortezomib and/or dexamethasone to treat multiple myeloma in adults.

Xpovio 40 mg twice-weekly is also used in adults to treat certain types of diffuse large B-cell lymphoma.

Xpovio 40 mg twice-weekly is given after other medications did not work or have stopped working.

Xpovio 40 mg twice-weekly was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to Xpovio 40 mg twice-weekly, but further studies are needed.

Xpovio 40 mg twice-weekly may also be used for purposes not listed in this medication guide.

Warnings

You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, flu symptoms, cough, mouth ulcers, or trouble breathing,

Xpovio 40 mg twice-weekly can also cause low platelet counts in your blood. Tell your doctor right away if you have unusual bruising or bleeding.

How should I use Xpovio 40 mg twice-weekly

Your doctor will perform tests to make sure Xpovio 40 mg twice-weekly is the right treatment for you.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Xpovio 40 mg twice-weekly is usually taken only on specific days, once or twice per week. Follow your doctor's instructions very carefully about when and how to take this medicine with dexamethasone and/or bortezomib.

Your doctor will determine how long to treat you with Xpovio 40 mg twice-weekly and dexamethasone.

Take Xpovio 40 mg twice-weekly with a full glass of water. Swallow the tablet whole and do not crush, chew, or break it.

If you vomit shortly after taking Xpovio 40 mg twice-weekly, do not take another dose. Take your next dose as scheduled.

You may be given other medications to help prevent nausea, vomiting, or infections. Keep taking these medicines for as long as your doctor has prescribed.

You may get infections more easily, even serious or fatal infections. You will need frequent medical tests. You may need a transfusion if your blood platelets get too low.

Your blood sodium levels will need to be tested. If the levels get too low, your doctor may prescribe salt tablets or intravenous (IV) fluids to keep you from getting dehydrated.

Drink plenty of liquids to prevent dehydration, and eat enough calories to prevent weight loss.

Xpovio 40 mg twice-weekly can affect your appetite or ability to eat. You will be weighed before and during treatment to make sure you are not losing weight while taking this medicine.

Store at room temperature away from moisture and heat. Keep each Xpovio 40 mg twice-weekly tablet in the blister pack until you are ready to take your dose.

Detailed Xpovio dosage information

Before Taking

Tell your doctor if you have ever had:

  • cataracts;

  • bleeding problems; or

  • an active or recent infection.

You may need to have a negative pregnancy test before starting this treatment.

Both men and women using Xpovio 40 mg twice-weekly should use effective birth control to prevent pregnancy. Xpovio 40 mg twice-weekly can harm an unborn baby if the mother or father is using this medicine.

Keep using birth control for at least 1 week after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Xpovio 40 mg twice-weekly.

This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because Xpovio 40 mg twice-weekly can harm an unborn baby.

Do not breastfeed while using this medicine, and for at least 1 week after your last dose.

Not approved for use by anyone younger than 18 years old.

What happens if I miss a dose?

Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Xpovio 40 mg twice-weekly?

Avoid driving or hazardous activity until you know how Xpovio 40 mg twice-weekly will affect you. Your reactions could be impaired.

Xpovio 40 mg twice-weekly side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Xpovio 40 mg twice-weekly can cause serious or fatal side effects. Some side effects may not occur until you have been taking this medicine for several days or weeks.

Xpovio 40 mg twice-weekly may cause serious side effects. Call your doctor at once if you have:

  • blurred vision, tunnel vision, eye pain, or seeing halos around lights;

  • severe ongoing nausea, vomiting, or diarrhea;

  • loss of appetite that prevents you from eating and causes weight loss;

  • confusion, dizziness, fainting, or changes in mental status;

  • symptoms of sepsis--fever or chills, severe drowsiness, fast heartbeats, rapid breathing, feeling very ill;

  • signs of infection--fever, chills, flu symptoms, cough with mucus, mouth and throat ulcers, feeling short of breath, tingly or painful blistering rash on one side of your body; or

  • low sodium level--headache, slurred speech, severe weakness, vomiting, loss of coordination, feeling unsteady.

Your treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of Xpovio 40 mg twice-weekly may include:

  • double vision, blurred vision, sensitivity to light or glare;

  • tiredness;

  • numbness, tingling, or burning pain in your hands or feet;

  • anemia, bruising or bleeding;

  • increased blood sugar;

  • fever, infections, cold or flu symptoms;

  • changes in sodium and mineral levels;

  • abnormal liver or kidney function tests;

  • nausea, vomiting, loss of appetite;

  • diarrhea, constipation;

  • weight loss; or

  • shortness of breath.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Xpovio 40 mg twice-weekly?

Other drugs may affect Xpovio 40 mg twice-weekly, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

More about Xpovio 40 mg twice-weekly (Selinexor [ sel-i-nex-or ])

Drug images
Side effects
Drug class: Miscellaneous antineoplastics
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by